Grifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down Debt
By David Sachs
Grifols shares jumped Friday after the pharmaceutical company said it will sell a sizable stake in a Chinese medicine developer for $1.76 billion in order to pay down debt.
The Barcelona-based group said Friday that it will sell a roughly 20% stake in Shanghai RAAS Blood Products to Haier Group, a Chinese appliance company with a biomedical unit, for 12.5 billion Chinese yuan. Grifols will use the proceeds to pay off debt, it said.
At 1417 GMT, shares in Grifols were up 9.4% to EUR15.57, having risen as high as EUR15.92.
Grifols will still hold an approximate stake of 6.6% in Shanghai RAAS and a seat on its board of directors following the transaction, which is subject to standard regulatory closing conditions, the company said.
"Grifols and Haier envision broad cooperation to contribute to China's growing and developing healthcare system," Grifols said.
Shanghai RAAS's 45% stake in Grifols Diagnostic Solutions and 40% voting rights in the company will remain the same.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
December 29, 2023 09:44 ET (14:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back